About Us

/
ARABIRA

ARABIRA

/
ARABIRA
Loading...

ARABIRA

Category:
Composition: Abiraterone Tablets
Strength: 250 mg

Description:

ARABIRA contains Abiraterone Acetate, a selective androgen biosynthesis inhibitor used in the treatment of prostate cancer. It works by inhibiting the CYP17 enzyme complex, which is crucial for the production of androgens (male hormones) in the testes, adrenal glands, and prostate tumor tissues.
By significantly reducing androgen levels, Abiraterone slows down the growth of androgen-dependent prostate cancer cells, especially in metastatic castration-resistant prostate cancer (mCRPC) and metastatic high-risk castration-sensitive prostate cancer (mCSPC).

Loading...

Description

Dosage and Administration
  • The standard dose is 1000 mg (4 tablets of 250 mg) once daily, taken at least 1 hour before or 2 hours after food.
  • Must be taken in combination with a corticosteroid (typically prednisone 5 mg twice daily).
  • Treatment should be supervised by an oncologist or urologist specialized in prostate cancer care.
  • Dose modifications may be required in case of liver toxicity or adverse reactions.
  • Fatigue
  • Joint pain
  • Hypertension
  • Fluid retention
  • Hot flashes
  • Low potassium levels
  • Elevated liver enzymes
  • Adrenal insufficiency
  • Liver toxicity
  • Severe hypokalemia
  • Not indicated for use in women or children.
  • Contraindicated in pregnancy and lactation – may cause fetal harm.
  • Regular monitoring of liver function, blood pressure, serum potassium, and fluid retention is necessary.
  • Patients with a history of cardiovascular disease should be closely monitored.
  • Abiraterone should always be co-administered with corticosteroids to reduce the risk of mineralocorticoid-related adverse effects.
  • Inform the doctor about all ongoing medications, especially for hypertension, diabetes, or heart disease.